Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Nara Organics Recalls Baby Formula Tied to Multistate Botulism Cases

Nara Organics initiated a nationwide recall of its organic baby formula Saturday following reports of infant botulism cases across multiple states. The formula, sold through Target stores and online retailers, prompted action from federal health authorities.

07/08/2026 · Kentucky edition

Advertisement

Advertisement

Nara Organics recalled its organic baby formula nationwide Saturday after federal authorities connected the product to cases of infant botulism across multiple states.

The company distributed the formula through Target locations and online channels. Federal health officials identified the link between the formula and the botulism outbreak, prompting the recall action.

Infant botulism develops when babies ingest spores of the bacterium Clostridium botulinum, which can produce toxins in the intestinal tract. Symptoms include constipation, weakness, poor feeding, and a weak cry. Severe cases can lead to paralysis and respiratory failure.

Federal authorities did not immediately release the number of confirmed cases or affected states. The investigation into how contamination occurred remained ongoing.

Consumers who purchased Nara Organics formula were advised to stop using the product and contact poison control or seek medical attention if their infants showed symptoms of botulism. The recall affected formula sold in multiple package sizes and lot numbers.

This outbreak marks another instance of contamination concerns in the infant formula market. Prior incidents have prompted increased scrutiny of manufacturing practices and quality controls across the industry.

Nara Organics cooperated with federal health agencies on the recall process. The company did not immediately provide additional details about the source of contamination or steps taken to prevent future incidents.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1102873 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Kentucky

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Kentucky

health

Supreme Court Begins Term with Key Arguments, Denies Hundreds of Cases

The Supreme Court began its new term by hearing arguments in two cases on Monday, focusing on climate change liability and veterans' benefits. The court also denied review in hundreds of cases, including disputes over student speech and COVID-19 vaccine mandates. Future arguments will address retirement fund management and federal environmental laws.

Read Story →
health

Trump Administration Finalizes Healthcare Transparency Rule

The Trump administration has issued a final rule regarding transparency in healthcare coverage. Health and Human Services Secretary Robert F. Kennedy Jr. stated the regulation offers a 'clear view of what healthcare actually costs.' This initiative seeks to increase consumer understanding of medical expenses.

Read Story →
health

GLP-1 Medications See Increased Use, Spur Research into New Applications

GLP-1 medications are now used by an estimated one in eight Americans. Researchers continue to investigate new potential applications for these drugs. The expansion in use prompts further questions and research.

Read Story →
health

Bipartisan Concern Grows Over Pharmacy Benefit Managers

Republicans and Democrats alike are directing scrutiny toward pharmacy benefit managers, or PBMs. Tennessee and Arkansas have already implemented regulations targeting these healthcare companies. This convergence of political and public opinion highlights increasing pressure on PBM operations.

Read Story →
health

Voters Seek Clear Policy Details, Economic Security from Candidates

Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.

Read Story →
health

Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial

Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.

Read Story →
Scroll for more stories